TRIKARSHIKA GHANAVATI IN THE MANAGEMENT OF VAATARAKTA WITH SPECIAL REFERENCE TO GOUT: A COMPREHENSIVE REVIEW

Background: Vaatarakta is an Ayurvedic disorder caused by the vitiation of Vata Dosha and Rakta Dhatu and is clinically comparable to gout, a crystal-induced inflammatory arthritis associated with hyperuricemia. Trikarshika Ghanavati, a classical formulation containing Guduchi (Tinospora cordifolia), Shunthi (Zingiber officinale), and Dhanyaka (Coriandrum sativum), is indicated in Chakradatta for the management of Vaatarakta. Experimental studies suggest anti-inflammatory, antioxidant, immunomodulatory, and potential anti-hyperuricemic activities of its ingredients.[1-4] Objective: To review the classical Ayurvedic literature and available scientific evidence regarding the role of Trikarshika Ghanavati in the management of Vaatarakta with special reference to gout. Materials and Methods: A narrative review was conducted using classical Ayurvedic texts and published literature retrieved from PubMed, Scopus, Google Scholar, and the AYUSH Research Portal. Results: Classical Ayurvedic literature describes Trikarshika as a Pachana Yoga for Vaatarakta. Its ingredients—Guduchi, Shunthi, and Dhanyaka—exhibit anti-inflammatory, antioxidant, nephroprotective, and potential anti-hyperuricemic activities, supporting their role in improving Agni, reducing Ama, and managing gout. Conclusion: The available evidence suggests that Trikarshika Ghanavati has considerable therapeutic potential in the management of Vaatarakta owing to its multidimensional pharmacological and Ayurvedic actions. Nevertheless, adequately powered randomized controlled trials are required to establish its efficacy and safety in patients with gout.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-07-16
DOI
https://doi.org/10.5281/zenodo.21407599
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TRIKARSHIKA GHANAVATI IN THE MANAGEMENT OF VAATARAKTA WITH SPECIAL REFERENCE TO GOUT: A COMPREHENSIVE REVIEW

Vd. Popat Vishvanath Jagtap2 Vd. Divya Shriniwas Pogul*1
Zenodo (CERN European Organization for Nuclear Research)
Phytochemicals and Medicinal Plants
article

TRIKARSHIKA GHANAVATI IN THE MANAGEMENT OF VAATARAKTA WITH SPECIAL REFERENCE TO GOUT: A COMPREHENSIVE REVIEW

Vd. Popat Vishvanath Jagtap2 Vd. Divya Shriniwas Pogul*1
article en

Abstract

Background: Vaatarakta is an Ayurvedic disorder caused by the vitiation of Vata Dosha and Rakta Dhatu and is clinically comparable to gout, a crystal-induced inflammatory arthritis associated with hyperuricemia. Trikarshika Ghanavati, a classical formulation containing Guduchi (Tinospora cordifolia), Shunthi (Zingiber officinale), and Dhanyaka (Coriandrum sativum), is indicated in Chakradatta for the management of Vaatarakta. Experimental studies suggest anti-inflammatory, antioxidant, immunomodulatory, and potential anti-hyperuricemic activities of its ingredients.[1-4] Objective: To review the classical Ayurvedic literature and available scientific evidence regarding the role of Trikarshika Ghanavati in the management of Vaatarakta with special reference to gout. Materials and Methods: A narrative review was conducted using classical Ayurvedic texts and published literature retrieved from PubMed, Scopus, Google Scholar, and the AYUSH Research Portal. Results: Classical Ayurvedic literature describes Trikarshika as a Pachana Yoga for Vaatarakta. Its ingredients—Guduchi, Shunthi, and Dhanyaka—exhibit anti-inflammatory, antioxidant, nephroprotective, and potential anti-hyperuricemic activities, supporting their role in improving Agni, reducing Ama, and managing gout. Conclusion: The available evidence suggests that Trikarshika Ghanavati has considerable therapeutic potential in the management of Vaatarakta owing to its multidimensional pharmacological and Ayurvedic actions. Nevertheless, adequately powered randomized controlled trials are required to establish its efficacy and safety in patients with gout.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 5%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.